Search for: "Roche Holding Ltd" Results 41 - 60 of 83
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert… [read post]
21 Dec 2009, 5:24 am
Century City Apartments Property Services CC and Another v Century City Property Owners Association (Afro-IP)   Spain A branding miracle from: from bullring to shop windows (Class 46)   Ukraine Ukrainian Higher Economic Court denies Ferrero’s claim on Raffaello trade mark infringement: Group Ferrero v Landrin (Class 46)   United Kingdom EWHC on compensation for employee inventors whose patents are particularly beneficial to employers: Shanks v Unilever plc & Ors (IPKat)… [read post]
5 Jan 2008, 6:00 am
: (IPEG),EU CORDIS launches a new web service for joint research initiatives: (IPR Helpdesk),EC announces plan to create single, EU-wide market for online music, films, and video games: (Ars Technica)GermanyGermans shun patents, but press for patent valuation ISO: (IPKat)Hong KongCreative commons Hong Kong begins public discussion (Creativecommons.com)IndiaBlawging our way to the front pages of Business Standard: (Spicy IP),Bootleg baloney: It's music to… [read post]
30 Jul 2009, 8:45 pm
., Ltd., 292 F.3d 1363, 1373 (Fed. [read post]
19 Dec 2009, 1:58 am
Hoffmann-La Roche, Ltd., 580 F.3d 1340, 1370 (Fed. [read post]
12 Sep 2008, 2:33 pm
: (IPRoo), Review of National Innovation System – Key points for corporate counsel: (Mallesons Stephen Jaques), Review of National Innovation System recommends creative commons: (creativecommons.org), Review of Innovation System released: (IP Menu News), What [right]’s in a [business] name: Westpac Banking Corporation v McMillan & Melbas On The Park Pty Ltd (formerly Credit Systems Australia Pty Ltd): (Australian Trade Marks Law Blog), Senator Kim Carr… [read post]
7 Mar 2008, 2:00 am
UK Ltd clarifies law on keywords and sponsored search results: (IPKat), (Class 46), (Out-Law), Discussion of the End Software Patents initiative: (Peter Zura's 271 Patent Blog), (IAM), (IAM), (Patent Prospector), (IAM), (Securing Innovation), Global Global - General IP valuation – a Pandora’s box? [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design field… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Feb 2008, 12:00 am
: Industries Ltd v Dynamic Supply Pty Ltd: (IP Down Under)BrazilIFPI raids hundreds of internet cafes: 600 cops, one arrest: (Ars Technica)CanadaInterlocutory injunctions in trade mark cases: a difficult test to meet: CMAC Mortgages v Canadian Mortgage Expert Centre and CanadaHyundai Autov Cross Canada Auto Body Supply: (Canadian Trademark Blog), (coverage of Hyundia - IPblog), Privacy Coalition warns on copyright reform: (Michael Geist),Wikinomics on… [read post]
7 Oct 2013, 11:06 am by Lawrence B. Ebert
Hoffman-LA Roche Ltd., 580 F.3d 1340, 1362 (Fed. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]